NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

表紙
市場調查報告書

全球自動注射器市場:按治療,產品類型,最終用戶,應用,預測(∼2025年),COVID-19的累積影響進行的市場研究

Auto-Injectors Market Research Report by Therapy, by Product Type, by End-user, by Application, by Region - Global Forecast to 2026 - Cumulative Impact of COVID-19

出版商 360iResearch LLP 商品編碼 998402
出版日期 內容資訊 英文 189 Pages
商品交期: 最快1-2個工作天內
價格
全球自動注射器市場:按治療,產品類型,最終用戶,應用,預測(∼2025年),COVID-19的累積影響進行的市場研究 Auto-Injectors Market Research Report by Therapy, by Product Type, by End-user, by Application, by Region - Global Forecast to 2026 - Cumulative Impact of COVID-19
出版日期: 2021年06月01日內容資訊: 英文 189 Pages
簡介

全球自動注射器市場預計將從2020年的39,586,280,000美元增長到2025年底的93,274,740,000美元。

市場細分和覆蓋範圍:

這份研究報告對自動注射器的全球市場進行了分類,預測了收入,並分析了以下每個子市場的趨勢:

    通過治療,已經對過敏性,糖尿病,多發性硬化症和類風濕關節炎的自動注射器市場進行了調查。
  • 按產品類型,自動注射器市場遍及一次性自動注射器和可重複使用的自動注射器。可重複使用的自動注射器在空中和預填充物上進行了進一步的研究。
  • 最終用戶對門診手術中心,家庭護理設施以及醫院和診所的自動注射器市場進行了調查。 通過應用,對自動注射器市場進行了研究,涉及過敏性反應,貧血,心血管疾病,糖尿病,偏頭痛,多發性硬化症,牛皮癬和類風濕性關節炎。
  • 按地區劃分,在美洲,亞太地區,歐洲和中東/非洲分別對自動注射器市場進行了調查。美洲是阿根廷,巴西,加拿大,墨西哥和美國。亞太地區是澳大利亞,中國,印度,印度尼西亞,日本,馬來西亞,菲律賓,韓國和泰國。在法國,德國,意大利,荷蘭,卡塔爾,俄羅斯,沙特阿拉伯,南非,西班牙,阿拉伯聯合酋長國和英國對歐洲以及中東和非洲地區進行了調查。

企業可用性配置文件:

報告包括Abbvie Inc.,Amgen Inc.,Antares Pharma,Inc,AstraZeneca PLC,Bayer AG,Becton,Dickinson and Company,Bespak(Recipharm AB),Biogen Inc,Bristol Myers Squibb,Eli Lilly and Company,F.霍夫曼-拉羅什(Hoffmann-La Roche)AG,葛蘭素史克(GlaxoSmithKline)PLC,哈瑟邁爾(Haselmeier GmbH),強生公司,Medeca Pharma AB,默克集團,Mylan NV,諾華公司,歐文芒福德(Owen Mumford),輝瑞公司,RAVIMED,賽諾菲(Sanofi)SA,斯堪的納維亞健康有限公司。 SHL Medical,Teva Pharmaceutical Industries Ltd.,Ypsomed Holding和全球市場上的其他主要供應商已經探索了近期的重大發展和創新概況。

COVID-19的累積影響:

預計COVID-19將在預測期內對行業增長產生長期影響,因為這是無與倫比的全球公共衛生突發事件,幾乎影響了每個行業。我們正在進行的研究擴大了研究框架,以確保它包括潛在的COVID-19問題和潛在的未來路徑。該調查提供了有關COVID-19的見解,並考慮了消費者行為和需求,購買模式,供應鏈改路,當前市場勢力動態以及政府的主要干預措施的變化。更新後的調查提供了見解,分析,估計和預測,其中考慮了COVID-19對市場的影響。

本報告調查了自動注射器的全球市場,提供了市場概況,對市場增長和障礙的分析,市場機會,COVID-19的影響,治療/產品類型/最終用戶/應用/地區,並提供了系統的信息例如市場規模趨勢和預測,競爭狀況以及主要公司的概況。

360iResearch(TM)FPNV定位矩陣:

360iResearch(TM)FPNV定位矩陣提供業務戰略(業務增長,行業覆蓋範圍,財務可行性,渠道支持),以幫助公司做出更好的決策並瞭解其競爭格局,並根據產品滿意度對市場中的供應商進行評估和分類(性價比,易用性,產品功能和客戶支持)。

360iResearch(TM)競爭戰略窗口:

360iResearch(TM)競爭戰略窗口從市場,應用和區域角度分析競爭條件。這有助於供應商定義能力和機會之間的協調或適應,以實現未來的增長前景。在預測期內,供應商將採用持續的併購策略,區域擴展,研發和新產品實施策略,以最佳或有利地適應進一步的業務擴展和增長。

此報告提供有關以下準則的見解:

  • 1.市場滲透率:主要參與者提供的全面市場信息
  • 2.市場開發:有利可圖的新興市場的詳細信息和市場分析
  • 3.市場多元化:有關新產品發佈,欠發達地區,最新發展和投資的更多信息
  • 4.競爭評估和情報:全面評估主要公司的市場份額,戰略,產品和製造能力
  • 5.產品開發和創新:對未來技術,研發活動和新產品開發的智能見解

此報告回答以下問題

  • 1. 全球市場的規模和預測是多少?
  • 2. 在預測期內,COVID-19形成市場的障礙和影響是什麼?
  • 3. 在預測期內,您將投資哪些產品,細分,應用或領域?
  • 4. 市場機會的競爭性戰略窗口是什麼?
  • 5. 市場的技術趨勢和監管框架是什麼?
  • 6. 您認為適合進入市場的方式和戰略舉措是什麼?

目錄

第1章簡介

  • 調查目的
  • 市場細分和覆蓋範圍
  • 考慮調查的年份
  • 貨幣和價格
  • 語言
  • 限制
  • 利益相關者

第2章調查方法

  • 調查過程
    • 定義:調查目的
    • 決策:調查設計
    • 準備:測量設備
    • 集合:數據源
    • 分析:數據解釋
    • 公式:數據驗證
    • 已發佈:調查報告
    • 重複:報告更新
  • 進行調查
    • 開始:調查過程
    • 計劃:創建調查計劃
    • 執行:進行調查
    • 驗證:發現和分析
    • 出版物:調查報告
  • 調查結果

第3章執行摘要

  • 市場前景
  • 使用前景
  • 治療前景
  • 最終用戶展望
  • 產品類型展望
  • 區域展望
  • 競爭對手展望

第4章市場概述

  • COVID-19的累積效果

第5章市場洞察

  • 市場動態
    • 促進因素
    • 抑製器
    • 市場機會
    • 挑戰
  • 搬運工五力分析
    • 新進入者的威脅
    • 替代威脅
    • 客戶的議價能力
    • 供應商的談判能力
    • 行業競爭

第6章通過治療

  • 過敏反應
  • 糖尿病
  • 多發性硬化症
  • 類風濕關節炎

第7章,按產品類型

  • 一次性自動注射器
  • 可重複使用的自動注射器
    • 預填充

最終用戶第8章

  • 門診手術中心
  • 家庭醫療
  • 醫院和診所

第9章,按應用程序

  • 過敏反應
  • 貧血
  • 心血管疾病
  • 糖尿病
  • 偏頭痛
  • 多發性硬化症
  • 牛皮癬
  • 類風濕關節炎

第10章美洲

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第11章亞太

  • 澳大利亞
  • 中國
  • 印度
  • 印度尼西亞
  • 日本
  • 馬來西亞
  • 菲律賓
  • 韓國
  • 泰國

第12章歐洲,中東/非洲

  • 法國
  • 德國
  • 意大利
  • 荷蘭
  • 卡塔爾
  • 俄羅斯
  • 沙特阿拉伯
  • 南非
  • 西班牙
  • 阿拉伯聯合酋長國
  • 英國

第13章競爭情況

  • FPNV Positioning Matrix
    • 象限
    • 經營策略
    • 產品滿意度
  • 市場排名分析
  • 市場份額分析
  • 競爭性SWOT分析
  • 衝突情況
    • 併購
    • 協議,合作和夥伴關係
    • 推出和增強新產品
    • 投融資
    • 獎項,獎項,擴展

第14章企業可用性概況

  • Abbvie Inc.
  • Amgen Inc.
  • Antares Pharma, Inc
  • AstraZeneca PLC
  • Bayer AG
  • Becton, Dickinson and Company
  • Bespak (Recipharm AB)
  • Biogen Inc
  • Bristol Myers Squibb
  • Eli Lilly and Company
  • F. Hoffmann-La Roche AG
  • GlaxoSmithKline PLC
  • Haselmeier GmbH
  • Johnson & Johnson Services, Inc
  • Medeca Pharma AB
  • Merck Group
  • Mylan N.V.
  • Novartis AG
  • Owen Mumford
  • Pfizer, Inc.
  • RAVIMED
  • Sanofi S.A.
  • Scandinavian Health Ltd.
  • SHL Medical
  • Teva Pharmaceutical Industries Ltd.
  • Ypsomed Holding

第15章附錄

  • 討論指南
  • 許可證和價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: MRR-ED54C46E91F1

The Global Auto-Injectors Market size was estimated at USD 39.58 Billion in 2020 and expected to reach USD 47.18 Billion in 2021, at a Compound Annual Growth Rate (CAGR) 19.53% to reach USD 115.49 Billion by 2026.

Market Statistics:

The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2019 are considered historical years, 2020 as the base year, 2021 as the estimated year, and years from 2022 to 2026 are considered the forecast period.

Market Segmentation & Coverage:

This research report categorizes the Auto-Injectors to forecast the revenues and analyze the trends in each of the following sub-markets:

Based on Therapy, the Auto-Injectors Market was studied across Anaphylaxis, Diabetes, Multiple Sclerosis, and Rheumatoid Arthritis.

Based on Product Type, the Auto-Injectors Market was studied across Disposable auto-injectors and Reusable auto-injectors. The Reusable auto-injectors is further studied across Empty and Prefilled.

Based on End-user, the Auto-Injectors Market was studied across Ambulatory Surgical Centers, Homecare Settings, and Hospitals & Clinics.

Based on Application , the Auto-Injectors Market was studied across Anaphylaxis, Anemia, Cardiovascular Diseases, Diabetes, Migraines, Multiple Sclerosis, Psoriasis, and Rheumatoid Arthritis.

Based on Geography, the Auto-Injectors Market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific is further studied across China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:

COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Auto-Injectors Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Company Usability Profiles:

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Auto-Injectors Market, including Abbvie Inc., Amgen Inc., Antares Pharma, Inc, AstraZeneca PLC, Bayer AG, Becton, Dickinson and Company, Bespak (Recipharm AB), Biogen Inc, Bristol Myers Squibb, Eli Lilly and Company, F. Hoffmann-La Roche AG, GlaxoSmithKline PLC, Haselmeier GmbH, Johnson & Johnson Services, Inc, Medeca Pharma AB, Merck Group, Mylan N.V., Novartis AG, Owen Mumford, Pfizer, Inc., RAVIMED, Sanofi S.A., Scandinavian Health Ltd., SHL Medical, Teva Pharmaceutical Industries Ltd., and Ypsomed Holding.

The report provides insights on the following pointers:

  • 1. Market Penetration: Provides comprehensive information on the market offered by the key players
  • 2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
  • 3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
  • 4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
  • 5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

  • 1. What is the market size and forecast of the Global Auto-Injectors Market?
  • 2. What are the inhibiting factors and impact of COVID-19 shaping the Global Auto-Injectors Market during the forecast period?
  • 3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Auto-Injectors Market?
  • 4. What is the competitive strategic window for opportunities in the Global Auto-Injectors Market?
  • 5. What are the technology trends and regulatory frameworks in the Global Auto-Injectors Market?
  • 6. What is the market share of the leading vendors in the Global Auto-Injectors Market?
  • 7. What modes and strategic moves are considered suitable for entering the Global Auto-Injectors Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

  • 3.1. Introduction
  • 3.2. Market Outlook
  • 3.3. Application Outlook
  • 3.4. Therapy Outlook
  • 3.5. End-user Outlook
  • 3.6. Product Type Outlook
  • 3.7. Geography Outlook
  • 3.8. Competitor Outlook

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising prevalence of anaphylaxis
      • 5.1.1.2. Increasing inclination self-administration of injections
      • 5.1.1.3. Growing geriatric population
      • 5.1.1.4. Increasing demand over the benefits offered such as less painful and more control
    • 5.1.2. Restraints
      • 5.1.2.1. Alternatives in the market such as continuous glucose monitoring devices
    • 5.1.3. Opportunities
      • 5.1.3.1. Innovations in device functionality
      • 5.1.3.2. Increasing penetration of home-care services
    • 5.1.4. Challenges
      • 5.1.4.1. Lack of awareness for proper use
  • 5.2. Cumulative Impact of COVID-19
  • 5.3. Porters Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry

6. Auto-Injectors Market, by Therapy

  • 6.1. Introduction
  • 6.2. Anaphylaxis
  • 6.3. Diabetes
  • 6.4. Multiple Sclerosis
  • 6.5. Rheumatoid Arthritis

7. Auto-Injectors Market, by Product Type

  • 7.1. Introduction
  • 7.2. Disposable auto-injectors
  • 7.3. Reusable auto-injectors
    • 7.3.1. Empty
    • 7.3.2. Prefilled

8. Auto-Injectors Market, by End-user

  • 8.1. Introduction
  • 8.2. Ambulatory Surgical Centers
  • 8.3. Homecare Settings
  • 8.4. Hospitals & Clinics

9. Auto-Injectors Market, by Application

  • 9.1. Introduction
  • 9.2. Anaphylaxis
  • 9.3. Anemia
  • 9.4. Cardiovascular Diseases
  • 9.5. Diabetes
  • 9.6. Migraines
  • 9.7. Multiple Sclerosis
  • 9.8. Psoriasis
  • 9.9. Rheumatoid Arthritis

10. Americas Auto-Injectors Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States
    • 10.6.1. California
    • 10.6.2. Florida
    • 10.6.3. Illinois
    • 10.6.4. New York
    • 10.6.5. Ohio
    • 10.6.6. Pennsylvania
    • 10.6.7. Texas

11. Asia-Pacific Auto-Injectors Market

  • 11.1. Introduction
  • 11.2. China
  • 11.3. India
  • 11.4. Indonesia
  • 11.5. Japan
  • 11.6. Malaysia
  • 11.7. Philippines
  • 11.8. South Korea
  • 11.9. Thailand

12. Europe, Middle East & Africa Auto-Injectors Market

  • 12.1. Introduction
  • 12.2. France
  • 12.3. Germany
  • 12.4. Italy
  • 12.5. Netherlands
  • 12.6. Qatar
  • 12.7. Russia
  • 12.8. Saudi Arabia
  • 12.9. South Africa
  • 12.10. Spain
  • 12.11. United Arab Emirates
  • 12.12. United Kingdom

13. Competitive Landscape

  • 13.1. FPNV Positioning Matrix
    • 13.1.1. Quadrants
    • 13.1.2. Business Strategy
    • 13.1.3. Product Satisfaction
  • 13.2. Market Ranking Analysis
  • 13.3. Market Share Analysis, By Quadrant
  • 13.4. Market Share Analysis, By Company
  • 13.5. Competitive Scenario
    • 13.5.1. Merger & Acquisition
    • 13.5.2. Agreement, Collaboration, & Partnership
    • 13.5.3. New Product Launch & Enhancement
    • 13.5.4. Investment & Funding
    • 13.5.5. Award, Recognition, & Expansion

14. Company Usability Profiles

  • 14.1. Abbvie Inc.
  • 14.2. Amgen Inc.
  • 14.3. Antares Pharma, Inc
  • 14.4. AstraZeneca PLC
  • 14.5. Bayer AG
  • 14.6. Becton, Dickinson and Company
  • 14.7. Bespak (Recipharm AB)
  • 14.8. Biogen Inc
  • 14.9. Bristol Myers Squibb
  • 14.10. Eli Lilly and Company
  • 14.11. F. Hoffmann-La Roche AG
  • 14.12. GlaxoSmithKline PLC
  • 14.13. Haselmeier GmbH
  • 14.14. Johnson & Johnson Services, Inc
  • 14.15. Medeca Pharma AB
  • 14.16. Merck Group
  • 14.17. Mylan N.V.
  • 14.18. Novartis AG
  • 14.19. Owen Mumford
  • 14.20. Pfizer, Inc.
  • 14.21. RAVIMED
  • 14.22. Sanofi S.A.
  • 14.23. Scandinavian Health Ltd.
  • 14.24. SHL Medical
  • 14.25. Teva Pharmaceutical Industries Ltd.
  • 14.26. Ypsomed Holding

15. Appendix

  • 15.1. Discussion Guide
  • 15.2. License & Pricing
  • 15.3. Contact Details

LIST OF FIGURES

  • FIGURE 1. GLOBAL AUTO-INJECTORS MARKET SIZE, 2020 VS 2026 (USD BILLION)
  • FIGURE 2. GLOBAL AUTO-INJECTORS MARKET SIZE, BY APPLICATION , 2020 (USD BILLION)
  • FIGURE 3. GLOBAL AUTO-INJECTORS MARKET SIZE, BY THERAPY, 2020 (USD BILLION)
  • FIGURE 4. GLOBAL AUTO-INJECTORS MARKET SIZE, BY END-USER, 2020 (USD BILLION)
  • FIGURE 5. GLOBAL AUTO-INJECTORS MARKET SIZE, BY PRODUCT TYPE, 2020 (USD BILLION)
  • FIGURE 6. GLOBAL AUTO-INJECTORS MARKET SIZE, BY GEOGRAPHY, 2020 (USD BILLION)
  • FIGURE 7. GLOBAL AUTO-INJECTORS MARKET: MARKET DYNAMICS
  • FIGURE 8. GLOBAL AUTO-INJECTORS MARKET: PORTERS FIVE FORCES ANALYSIS
  • FIGURE 9. GLOBAL AUTO-INJECTORS MARKET SIZE, BY THERAPY, 2020 VS 2026 (%)
  • FIGURE 10. GLOBAL AUTO-INJECTORS MARKET SIZE, BY THERAPY, 2020 VS 2026 (USD BILLION)
  • FIGURE 11. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL AUTO-INJECTORS MARKET SIZE, BY THERAPY, 2026
  • FIGURE 12. GLOBAL AUTO-INJECTORS MARKET SIZE, BY ANAPHYLAXIS, 2018-2026 (USD BILLION)
  • FIGURE 13. GLOBAL AUTO-INJECTORS MARKET SIZE, BY ANAPHYLAXIS, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 14. GLOBAL AUTO-INJECTORS MARKET SIZE, BY DIABETES, 2018-2026 (USD BILLION)
  • FIGURE 15. GLOBAL AUTO-INJECTORS MARKET SIZE, BY DIABETES, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 16. GLOBAL AUTO-INJECTORS MARKET SIZE, BY MULTIPLE SCLEROSIS, 2018-2026 (USD BILLION)
  • FIGURE 17. GLOBAL AUTO-INJECTORS MARKET SIZE, BY MULTIPLE SCLEROSIS, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 18. GLOBAL AUTO-INJECTORS MARKET SIZE, BY RHEUMATOID ARTHRITIS, 2018-2026 (USD BILLION)
  • FIGURE 19. GLOBAL AUTO-INJECTORS MARKET SIZE, BY RHEUMATOID ARTHRITIS, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 20. GLOBAL AUTO-INJECTORS MARKET SIZE, BY PRODUCT TYPE, 2020 VS 2026 (%)
  • FIGURE 21. GLOBAL AUTO-INJECTORS MARKET SIZE, BY PRODUCT TYPE, 2020 VS 2026 (USD BILLION)
  • FIGURE 22. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL AUTO-INJECTORS MARKET SIZE, BY PRODUCT TYPE, 2026
  • FIGURE 23. GLOBAL AUTO-INJECTORS MARKET SIZE, BY DISPOSABLE AUTO-INJECTORS, 2018-2026 (USD BILLION)
  • FIGURE 24. GLOBAL AUTO-INJECTORS MARKET SIZE, BY DISPOSABLE AUTO-INJECTORS, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 25. GLOBAL AUTO-INJECTORS MARKET SIZE, BY REUSABLE AUTO-INJECTORS, 2018-2026 (USD BILLION)
  • FIGURE 26. GLOBAL AUTO-INJECTORS MARKET SIZE, BY REUSABLE AUTO-INJECTORS, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 27. GLOBAL AUTO-INJECTORS MARKET SIZE, BY EMPTY, 2018-2026 (USD BILLION)
  • FIGURE 28. GLOBAL AUTO-INJECTORS MARKET SIZE, BY EMPTY, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 29. GLOBAL AUTO-INJECTORS MARKET SIZE, BY PREFILLED, 2018-2026 (USD BILLION)
  • FIGURE 30. GLOBAL AUTO-INJECTORS MARKET SIZE, BY PREFILLED, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 31. GLOBAL AUTO-INJECTORS MARKET SIZE, BY END-USER, 2020 VS 2026 (%)
  • FIGURE 32. GLOBAL AUTO-INJECTORS MARKET SIZE, BY END-USER, 2020 VS 2026 (USD BILLION)
  • FIGURE 33. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL AUTO-INJECTORS MARKET SIZE, BY END-USER, 2026
  • FIGURE 34. GLOBAL AUTO-INJECTORS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2026 (USD BILLION)
  • FIGURE 35. GLOBAL AUTO-INJECTORS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 36. GLOBAL AUTO-INJECTORS MARKET SIZE, BY HOMECARE SETTINGS, 2018-2026 (USD BILLION)
  • FIGURE 37. GLOBAL AUTO-INJECTORS MARKET SIZE, BY HOMECARE SETTINGS, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 38. GLOBAL AUTO-INJECTORS MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2026 (USD BILLION)
  • FIGURE 39. GLOBAL AUTO-INJECTORS MARKET SIZE, BY HOSPITALS & CLINICS, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 40. GLOBAL AUTO-INJECTORS MARKET SIZE, BY APPLICATION , 2020 VS 2026 (%)
  • FIGURE 41. GLOBAL AUTO-INJECTORS MARKET SIZE, BY APPLICATION , 2020 VS 2026 (USD BILLION)
  • FIGURE 42. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL AUTO-INJECTORS MARKET SIZE, BY APPLICATION , 2026
  • FIGURE 43. GLOBAL AUTO-INJECTORS MARKET SIZE, BY ANAPHYLAXIS, 2018-2026 (USD BILLION)
  • FIGURE 44. GLOBAL AUTO-INJECTORS MARKET SIZE, BY ANAPHYLAXIS, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 45. GLOBAL AUTO-INJECTORS MARKET SIZE, BY ANEMIA, 2018-2026 (USD BILLION)
  • FIGURE 46. GLOBAL AUTO-INJECTORS MARKET SIZE, BY ANEMIA, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 47. GLOBAL AUTO-INJECTORS MARKET SIZE, BY CARDIOVASCULAR DISEASES, 2018-2026 (USD BILLION)
  • FIGURE 48. GLOBAL AUTO-INJECTORS MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 49. GLOBAL AUTO-INJECTORS MARKET SIZE, BY DIABETES, 2018-2026 (USD BILLION)
  • FIGURE 50. GLOBAL AUTO-INJECTORS MARKET SIZE, BY DIABETES, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 51. GLOBAL AUTO-INJECTORS MARKET SIZE, BY MIGRAINES, 2018-2026 (USD BILLION)
  • FIGURE 52. GLOBAL AUTO-INJECTORS MARKET SIZE, BY MIGRAINES, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 53. GLOBAL AUTO-INJECTORS MARKET SIZE, BY MULTIPLE SCLEROSIS, 2018-2026 (USD BILLION)
  • FIGURE 54. GLOBAL AUTO-INJECTORS MARKET SIZE, BY MULTIPLE SCLEROSIS, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 55. GLOBAL AUTO-INJECTORS MARKET SIZE, BY PSORIASIS, 2018-2026 (USD BILLION)
  • FIGURE 56. GLOBAL AUTO-INJECTORS MARKET SIZE, BY PSORIASIS, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 57. GLOBAL AUTO-INJECTORS MARKET SIZE, BY RHEUMATOID ARTHRITIS, 2018-2026 (USD BILLION)
  • FIGURE 58. GLOBAL AUTO-INJECTORS MARKET SIZE, BY RHEUMATOID ARTHRITIS, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 59. AMERICAS AUTO-INJECTORS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (%)
  • FIGURE 60. AMERICAS AUTO-INJECTORS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 61. COMPETITIVE STRATEGIC WINDOW FOR AMERICAS AUTO-INJECTORS MARKET SIZE, BY GEOGRAPHY, 2026
  • FIGURE 62. ARGENTINA AUTO-INJECTORS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 63. BRAZIL AUTO-INJECTORS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 64. CANADA AUTO-INJECTORS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 65. MEXICO AUTO-INJECTORS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 66. UNITED STATES AUTO-INJECTORS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 67. CALIFORNIA AUTO-INJECTORS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 68. FLORIDA AUTO-INJECTORS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 69. ILLINOIS AUTO-INJECTORS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 70. NEW YORK AUTO-INJECTORS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 71. OHIO AUTO-INJECTORS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 72. PENNSYLVANIA AUTO-INJECTORS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 73. TEXAS AUTO-INJECTORS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 74. ASIA-PACIFIC AUTO-INJECTORS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (%)
  • FIGURE 75. ASIA-PACIFIC AUTO-INJECTORS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 76. COMPETITIVE STRATEGIC WINDOW FOR ASIA-PACIFIC AUTO-INJECTORS MARKET SIZE, BY GEOGRAPHY, 2026
  • FIGURE 77. CHINA AUTO-INJECTORS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 78. INDIA AUTO-INJECTORS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 79. INDONESIA AUTO-INJECTORS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 80. JAPAN AUTO-INJECTORS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 81. MALAYSIA AUTO-INJECTORS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 82. PHILIPPINES AUTO-INJECTORS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 83. SOUTH KOREA AUTO-INJECTORS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 84. THAILAND AUTO-INJECTORS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 85. EUROPE, MIDDLE EAST & AFRICA AUTO-INJECTORS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (%)
  • FIGURE 86. EUROPE, MIDDLE EAST & AFRICA AUTO-INJECTORS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 87. COMPETITIVE STRATEGIC WINDOW FOR EUROPE, MIDDLE EAST & AFRICA AUTO-INJECTORS MARKET SIZE, BY GEOGRAPHY, 2026
  • FIGURE 88. FRANCE AUTO-INJECTORS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 89. GERMANY AUTO-INJECTORS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 90. ITALY AUTO-INJECTORS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 91. NETHERLANDS AUTO-INJECTORS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 92. QATAR AUTO-INJECTORS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 93. RUSSIA AUTO-INJECTORS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 94. SAUDI ARABIA AUTO-INJECTORS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 95. SOUTH AFRICA AUTO-INJECTORS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 96. SPAIN AUTO-INJECTORS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 97. UNITED ARAB EMIRATES AUTO-INJECTORS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 98. UNITED KINGDOM AUTO-INJECTORS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 99. GLOBAL AUTO-INJECTORS MARKET: FPNV POSITIONING MATRIX
  • FIGURE 100. GLOBAL AUTO-INJECTORS MARKET: SHARE, BY QUADRANT, 2020
  • FIGURE 101. GLOBAL AUTO-INJECTORS MARKET: SHARE, BY COMPANY, 2020
  • FIGURE 102. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL AUTO-INJECTORS MARKET, BY TYPE

LIST OF TABLES

  • TABLE 1. GLOBAL AUTO-INJECTORS MARKET: MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016-2020
  • TABLE 3. GLOBAL AUTO-INJECTORS MARKET SIZE, BY THERAPY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 4. GLOBAL AUTO-INJECTORS MARKET SIZE, BY ANAPHYLAXIS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 5. GLOBAL AUTO-INJECTORS MARKET SIZE, BY DIABETES, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 6. GLOBAL AUTO-INJECTORS MARKET SIZE, BY MULTIPLE SCLEROSIS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 7. GLOBAL AUTO-INJECTORS MARKET SIZE, BY RHEUMATOID ARTHRITIS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 8. GLOBAL AUTO-INJECTORS MARKET SIZE, BY PRODUCT TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 9. GLOBAL AUTO-INJECTORS MARKET SIZE, BY DISPOSABLE AUTO-INJECTORS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 10. GLOBAL AUTO-INJECTORS MARKET SIZE, BY REUSABLE AUTO-INJECTORS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 11. GLOBAL AUTO-INJECTORS MARKET SIZE, BY EMPTY, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 12. GLOBAL AUTO-INJECTORS MARKET SIZE, BY PREFILLED, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 13. GLOBAL AUTO-INJECTORS MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 14. GLOBAL AUTO-INJECTORS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 15. GLOBAL AUTO-INJECTORS MARKET SIZE, BY HOMECARE SETTINGS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 16. GLOBAL AUTO-INJECTORS MARKET SIZE, BY HOSPITALS & CLINICS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 17. GLOBAL AUTO-INJECTORS MARKET SIZE, BY APPLICATION , 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 18. GLOBAL AUTO-INJECTORS MARKET SIZE, BY ANAPHYLAXIS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 19. GLOBAL AUTO-INJECTORS MARKET SIZE, BY ANEMIA, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 20. GLOBAL AUTO-INJECTORS MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 21. GLOBAL AUTO-INJECTORS MARKET SIZE, BY DIABETES, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 22. GLOBAL AUTO-INJECTORS MARKET SIZE, BY MIGRAINES, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 23. GLOBAL AUTO-INJECTORS MARKET SIZE, BY MULTIPLE SCLEROSIS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 24. GLOBAL AUTO-INJECTORS MARKET SIZE, BY PSORIASIS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 25. GLOBAL AUTO-INJECTORS MARKET SIZE, BY RHEUMATOID ARTHRITIS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 26. AMERICAS AUTO-INJECTORS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 27. AMERICAS AUTO-INJECTORS MARKET SIZE, BY APPLICATION , 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 28. AMERICAS AUTO-INJECTORS MARKET SIZE, BY THERAPY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 29. AMERICAS AUTO-INJECTORS MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 30. AMERICAS AUTO-INJECTORS MARKET SIZE, BY PRODUCT TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 31. ARGENTINA AUTO-INJECTORS MARKET SIZE, BY APPLICATION , 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 32. ARGENTINA AUTO-INJECTORS MARKET SIZE, BY THERAPY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 33. ARGENTINA AUTO-INJECTORS MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 34. ARGENTINA AUTO-INJECTORS MARKET SIZE, BY PRODUCT TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 35. BRAZIL AUTO-INJECTORS MARKET SIZE, BY APPLICATION , 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 36. BRAZIL AUTO-INJECTORS MARKET SIZE, BY THERAPY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 37. BRAZIL AUTO-INJECTORS MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 38. BRAZIL AUTO-INJECTORS MARKET SIZE, BY PRODUCT TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 39. CANADA AUTO-INJECTORS MARKET SIZE, BY APPLICATION , 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 40. CANADA AUTO-INJECTORS MARKET SIZE, BY THERAPY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 41. CANADA AUTO-INJECTORS MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 42. CANADA AUTO-INJECTORS MARKET SIZE, BY PRODUCT TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 43. MEXICO AUTO-INJECTORS MARKET SIZE, BY APPLICATION , 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 44. MEXICO AUTO-INJECTORS MARKET SIZE, BY THERAPY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 45. MEXICO AUTO-INJECTORS MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 46. MEXICO AUTO-INJECTORS MARKET SIZE, BY PRODUCT TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 47. UNITED STATES AUTO-INJECTORS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 48. UNITED STATES AUTO-INJECTORS MARKET SIZE, BY APPLICATION , 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 49. UNITED STATES AUTO-INJECTORS MARKET SIZE, BY THERAPY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 50. UNITED STATES AUTO-INJECTORS MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 51. UNITED STATES AUTO-INJECTORS MARKET SIZE, BY PRODUCT TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 52. CALIFORNIA AUTO-INJECTORS MARKET SIZE, BY APPLICATION , 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 53. CALIFORNIA AUTO-INJECTORS MARKET SIZE, BY THERAPY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 54. CALIFORNIA AUTO-INJECTORS MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 55. CALIFORNIA AUTO-INJECTORS MARKET SIZE, BY PRODUCT TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 56. FLORIDA AUTO-INJECTORS MARKET SIZE, BY APPLICATION , 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 57. FLORIDA AUTO-INJECTORS MARKET SIZE, BY THERAPY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 58. FLORIDA AUTO-INJECTORS MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 59. FLORIDA AUTO-INJECTORS MARKET SIZE, BY PRODUCT TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 60. ILLINOIS AUTO-INJECTORS MARKET SIZE, BY APPLICATION , 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 61. ILLINOIS AUTO-INJECTORS MARKET SIZE, BY THERAPY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 62. ILLINOIS AUTO-INJECTORS MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 63. ILLINOIS AUTO-INJECTORS MARKET SIZE, BY PRODUCT TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 64. NEW YORK AUTO-INJECTORS MARKET SIZE, BY APPLICATION , 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 65. NEW YORK AUTO-INJECTORS MARKET SIZE, BY THERAPY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 66. NEW YORK AUTO-INJECTORS MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 67. NEW YORK AUTO-INJECTORS MARKET SIZE, BY PRODUCT TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 68. OHIO AUTO-INJECTORS MARKET SIZE, BY APPLICATION , 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 69. OHIO AUTO-INJECTORS MARKET SIZE, BY THERAPY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 70. OHIO AUTO-INJECTORS MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 71. OHIO AUTO-INJECTORS MARKET SIZE, BY PRODUCT TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 72. PENNSYLVANIA AUTO-INJECTORS MARKET SIZE, BY APPLICATION , 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 73. PENNSYLVANIA AUTO-INJECTORS MARKET SIZE, BY THERAPY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 74. PENNSYLVANIA AUTO-INJECTORS MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 75. PENNSYLVANIA AUTO-INJECTORS MARKET SIZE, BY PRODUCT TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 76. TEXAS AUTO-INJECTORS MARKET SIZE, BY APPLICATION , 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 77. TEXAS AUTO-INJECTORS MARKET SIZE, BY THERAPY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 78. TEXAS AUTO-INJECTORS MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 79. TEXAS AUTO-INJECTORS MARKET SIZE, BY PRODUCT TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 80. ASIA-PACIFIC AUTO-INJECTORS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 81. ASIA-PACIFIC AUTO-INJECTORS MARKET SIZE, BY APPLICATION , 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 82. ASIA-PACIFIC AUTO-INJECTORS MARKET SIZE, BY THERAPY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 83. ASIA-PACIFIC AUTO-INJECTORS MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 84. ASIA-PACIFIC AUTO-INJECTORS MARKET SIZE, BY PRODUCT TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 85. CHINA AUTO-INJECTORS MARKET SIZE, BY APPLICATION , 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 86. CHINA AUTO-INJECTORS MARKET SIZE, BY THERAPY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 87. CHINA AUTO-INJECTORS MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 88. CHINA AUTO-INJECTORS MARKET SIZE, BY PRODUCT TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 89. INDIA AUTO-INJECTORS MARKET SIZE, BY APPLICATION , 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 90. INDIA AUTO-INJECTORS MARKET SIZE, BY THERAPY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 91. INDIA AUTO-INJECTORS MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 92. INDIA AUTO-INJECTORS MARKET SIZE, BY PRODUCT TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 93. INDONESIA AUTO-INJECTORS MARKET SIZE, BY APPLICATION , 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 94. INDONESIA AUTO-INJECTORS MARKET SIZE, BY THERAPY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 95. INDONESIA AUTO-INJECTORS MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 96. INDONESIA AUTO-INJECTORS MARKET SIZE, BY PRODUCT TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 97. JAPAN AUTO-INJECTORS MARKET SIZE, BY APPLICATION , 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 98. JAPAN AUTO-INJECTORS MARKET SIZE, BY THERAPY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 99. JAPAN AUTO-INJECTORS MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 100. JAPAN AUTO-INJECTORS MARKET SIZE, BY PRODUCT TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 101. MALAYSIA AUTO-INJECTORS MARKET SIZE, BY APPLICATION , 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 102. MALAYSIA AUTO-INJECTORS MARKET SIZE, BY THERAPY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 103. MALAYSIA AUTO-INJECTORS MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 104. MALAYSIA AUTO-INJECTORS MARKET SIZE, BY PRODUCT TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 105. PHILIPPINES AUTO-INJECTORS MARKET SIZE, BY APPLICATION , 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 106. PHILIPPINES AUTO-INJECTORS MARKET SIZE, BY THERAPY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 107. PHILIPPINES AUTO-INJECTORS MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 108. PHILIPPINES AUTO-INJECTORS MARKET SIZE, BY PRODUCT TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 109. SOUTH KOREA AUTO-INJECTORS MARKET SIZE, BY APPLICATION , 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 110. SOUTH KOREA AUTO-INJECTORS MARKET SIZE, BY THERAPY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 111. SOUTH KOREA AUTO-INJECTORS MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 112. SOUTH KOREA AUTO-INJECTORS MARKET SIZE, BY PRODUCT TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 113. THAILAND AUTO-INJECTORS MARKET SIZE, BY APPLICATION , 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 114. THAILAND AUTO-INJECTORS MARKET SIZE, BY THERAPY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 115. THAILAND AUTO-INJECTORS MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 116. THAILAND AUTO-INJECTORS MARKET SIZE, BY PRODUCT TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 117. EUROPE, MIDDLE EAST & AFRICA AUTO-INJECTORS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 118. EUROPE, MIDDLE EAST & AFRICA AUTO-INJECTORS MARKET SIZE, BY APPLICATION , 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 119. EUROPE, MIDDLE EAST & AFRICA AUTO-INJECTORS MARKET SIZE, BY THERAPY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 120. EUROPE, MIDDLE EAST & AFRICA AUTO-INJECTORS MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 121. EUROPE, MIDDLE EAST & AFRICA AUTO-INJECTORS MARKET SIZE, BY PRODUCT TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 122. FRANCE AUTO-INJECTORS MARKET SIZE, BY APPLICATION , 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 123. FRANCE AUTO-INJECTORS MARKET SIZE, BY THERAPY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 124. FRANCE AUTO-INJECTORS MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 125. FRANCE AUTO-INJECTORS MARKET SIZE, BY PRODUCT TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 126. GERMANY AUTO-INJECTORS MARKET SIZE, BY APPLICATION , 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 127. GERMANY AUTO-INJECTORS MARKET SIZE, BY THERAPY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 128. GERMANY AUTO-INJECTORS MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 129. GERMANY AUTO-INJECTORS MARKET SIZE, BY PRODUCT TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 130. ITALY AUTO-INJECTORS MARKET SIZE, BY APPLICATION , 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 131. ITALY AUTO-INJECTORS MARKET SIZE, BY THERAPY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 132. ITALY AUTO-INJECTORS MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 133. ITALY AUTO-INJECTORS MARKET SIZE, BY PRODUCT TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 134. NETHERLANDS AUTO-INJECTORS MARKET SIZE, BY APPLICATION , 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 135. NETHERLANDS AUTO-INJECTORS MARKET SIZE, BY THERAPY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 136. NETHERLANDS AUTO-INJECTORS MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 137. NETHERLANDS AUTO-INJECTORS MARKET SIZE, BY PRODUCT TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 138. QATAR AUTO-INJECTORS MARKET SIZE, BY APPLICATION , 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 139. QATAR AUTO-INJECTORS MARKET SIZE, BY THERAPY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 140. QATAR AUTO-INJECTORS MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 141. QATAR AUTO-INJECTORS MARKET SIZE, BY PRODUCT TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 142. RUSSIA AUTO-INJECTORS MARKET SIZE, BY APPLICATION , 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 143. RUSSIA AUTO-INJECTORS MARKET SIZE, BY THERAPY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 144. RUSSIA AUTO-INJECTORS MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 145. RUSSIA AUTO-INJECTORS MARKET SIZE, BY PRODUCT TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 146. SAUDI ARABIA AUTO-INJECTORS MARKET SIZE, BY APPLICATION , 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 147. SAUDI ARABIA AUTO-INJECTORS MARKET SIZE, BY THERAPY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 148. SAUDI ARABIA AUTO-INJECTORS MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 149. SAUDI ARABIA AUTO-INJECTORS MARKET SIZE, BY PRODUCT TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 150. SOUTH AFRICA AUTO-INJECTORS MARKET SIZE, BY APPLICATION , 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 151. SOUTH AFRICA AUTO-INJECTORS MARKET SIZE, BY THERAPY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 152. SOUTH AFRICA AUTO-INJECTORS MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 153. SOUTH AFRICA AUTO-INJECTORS MARKET SIZE, BY PRODUCT TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 154. SPAIN AUTO-INJECTORS MARKET SIZE, BY APPLICATION , 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 155. SPAIN AUTO-INJECTORS MARKET SIZE, BY THERAPY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 156. SPAIN AUTO-INJECTORS MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 157. SPAIN AUTO-INJECTORS MARKET SIZE, BY PRODUCT TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 158. UNITED ARAB EMIRATES AUTO-INJECTORS MARKET SIZE, BY APPLICATION , 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 159. UNITED ARAB EMIRATES AUTO-INJECTORS MARKET SIZE, BY THERAPY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 160. UNITED ARAB EMIRATES AUTO-INJECTORS MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 161. UNITED ARAB EMIRATES AUTO-INJECTORS MARKET SIZE, BY PRODUCT TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 162. UNITED KINGDOM AUTO-INJECTORS MARKET SIZE, BY APPLICATION , 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 163. UNITED KINGDOM AUTO-INJECTORS MARKET SIZE, BY THERAPY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 164. UNITED KINGDOM AUTO-INJECTORS MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 165. UNITED KINGDOM AUTO-INJECTORS MARKET SIZE, BY PRODUCT TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 166. GLOBAL AUTO-INJECTORS MARKET: SCORES
  • TABLE 167. GLOBAL AUTO-INJECTORS MARKET: BUSINESS STRATEGY
  • TABLE 168. GLOBAL AUTO-INJECTORS MARKET: PRODUCT SATISFACTION
  • TABLE 169. GLOBAL AUTO-INJECTORS MARKET: RANKING
  • TABLE 170. GLOBAL AUTO-INJECTORS MARKET: SHARE, BY QUADRANT, 2020
  • TABLE 171. GLOBAL AUTO-INJECTORS MARKET: SHARE, BY COMPANY, 2020
  • TABLE 172. GLOBAL AUTO-INJECTORS MARKET: MERGER & ACQUISITION
  • TABLE 173. GLOBAL AUTO-INJECTORS MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
  • TABLE 174. GLOBAL AUTO-INJECTORS MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
  • TABLE 175. GLOBAL AUTO-INJECTORS MARKET: INVESTMENT & FUNDING
  • TABLE 176. GLOBAL AUTO-INJECTORS MARKET: AWARD, RECOGNITION, & EXPANSION
  • TABLE 177. GLOBAL AUTO-INJECTORS MARKET: LICENSE & PRICING
  • TABLE 178. GLOBAL AUTO-INJECTORS MARKET: CONTACT DETAILS